SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LSBC: Large Scale Biology Corp.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche3/5/2001 9:17:55 PM
   of 21
 
damn!.......

Monday March 5, 8:03 pm Eastern Time

Press Release

Large Scale Biology Corporation Media Advisory -
Company Presentation on March 7 Postponed Due to
Inclement Weather

VACAVILLE, Calif.--(BW HealthWire)--March 5, 2001--Large Scale Biology Corporation (NASDAQ: LSBC - news)
announced today that it's postponed the Company's scientific briefing and webcast on the first version of its inventory of
proteins in the human body, known as the Human Protein Index(TM) (HPI(TM)). The briefing was to be held on Wednesday,
March 7, from 9:30 AM to 12:00 PM at the New York Academy of Sciences in New York City.

A severe winter storm in the Northeast has forced the postponement of the briefing and webcast; both will be rescheduled at a
later date. All media and other individuals who have registered for the meeting and need further information may contact Dr.
Kathy Jones, of Burns McClellan, at (212) 213-0006.

Large Scale Biology Corporation is an industry leader in identifying and characterizing proteins in all types of biological samples
for the discovery and development of new and more effective disease diagnostics, therapeutics, vaccines and agricultural
products. Large Scale Biology has pioneered the development and application of many of the tools that are now considered
state-of-the-art in genomics and proteomics. Corporate offices and the Genomics and Antigenics divisions are headquartered in
Vacaville, California; the Company's Proteomics subsidiary is located in Germantown, Maryland; and the Company's
bioprocessing and manufacturing facilities are located in Owensboro, Kentucky. For more information about LSBC, visit the
Company's website at www.lsbc.com.

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements are based on our current plans, expectations, estimates, and projections and management's
beliefs about our future performance. Words such as ``anticipates,'' ``expects,'' ``intends,'' ``plans,'' ``believes,'' ``seeks,''
``estimates'' or variations of such words and similar expressions are intended to identify such forward-looking statements.
These statements are not guarantees of future performance and are subject to risks and uncertainties that are difficult to predict
and which may cause our actual results and performance to differ materially from those expressed or forecasted in any such
forward-looking statements. For a further list and description of such risks and uncertainties see the reports filed by Large
Scale Biology Corporation with the Securities Exchange Commission. Unless required by law, Large Scale Biology
Corporation undertakes no obligation to update publicly any forward-looking statements.

Contact:

Burns McClellan, New York
Dr. Kathy Jones, 212/213-0006
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext